The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

China Cord Blood Corp

NYSE: CO
Last

(U.S.) $6.16

Today's change-0.01 -0.16%
Updated May 22 4:02 PM EDT. Delayed by at least 15 minutes.
 

China Cord Blood Corp

NYSE: CO
Last

(U.S.) $6.16

Today's change-0.01 -0.16%
Updated May 22 4:02 PM EDT. Delayed by at least 15 minutes.

China Cord Blood Corp down (U.S.)$0.01

China Cord Blood Corp closed lower Friday, dropping (U.S.)$0.01 or 0.16% to (U.S.)$6.16. Over the last five days, shares have gained 0.49% and 36.28% year to date. Shares have outperformed the S&P 500 by 29.59% during the last year.

Key company metrics

  • Open(U.S.) $6.17
  • Previous close(U.S.) $6.17
  • High(U.S.) $6.17
  • Low(U.S.) $6.16
  • Bid / Ask-- / --
  • YTD % change+36.28%
  • Volume98,585
  • Average volume (10-day)141,756
  • Average volume (1-month)403,960
  • Average volume (3-month)314,622
  • 52-week range(U.S.) $4.10 to (U.S.) $7.24
  • Beta1.06
  • Trailing P/E21.96×
  • P/E 1 year forward25.67×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.28
Updated May 22 4:02 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.02%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue167152153152
Total other revenue--------
Total revenue167152153152
Gross profit131122124125
Total cost of revenue36303027
Total operating expense99959388
Selling / general / administrative60626158
Research & development2223
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income68576064
Interest income (expense), net non-operating-26-25-25-17
Gain (loss) on sale of assets--------
Other--------
Income before tax47374253
Income after tax34273040
Income tax, total14101213
Net income33273040
Total adjustments to net income-------15
Net income before extra. items33273040
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items33273024
Inc. avail. to common incl. extra. items33273024
Diluted net income33273024
Dilution adjustment----00
Diluted weighted average shares73737349
Diluted EPS excluding extraordinary itemsvalue per share0.460.370.410.50
Dividends per sharevalue per share------0.00
Diluted normalized EPSvalue per share0.460.370.410.50